Anti-ATP1A3 antibody [XVIF9-G10]
4
(5 Reviews)
|
(17 Publications)
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ATP1A3 antibody [XVIF9-G10] (AB2826)
Immunohistochemistry was performed on both normal and cancer biopsies of deparaffinized Human prostate carcinoma tissues. To expose target proteins heat induced antigen retrieval was performed using 10mM sodium citrate (pH6.0) buffer microwaved for 8-15 minutes. Following antigen retrieval tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Tissues were then probed at 1/50 dilution with ab2826 or without primary antibody (negative control) overnight at 4°C in a humidified chamber. Tissues were washed extensively with PBST and endogenous peroxidase activity was quenched with a peroxidase suppressor. Detection was performed using a biotin-conjugated secondary antibody and SA-HRP followed by colorimetric detection using DAB. Tissues were counterstained with hematoxylin and prepped for mounting.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ATP1A3 antibody [XVIF9-G10] (AB2826)
Immunofluorescent analysis of Sodium/Potassium ATPase alpha-3 using ab2826 shows staining in U251 glioma cells. Sodium/Potassium ATPase alpha-3 staining (green) F-Actin staining with Phalloidin (red) and nuclei with DAPI (blue) is shown. Cells were grown on chamber slides and fixed with formaldehyde prior to staining. Cells were probed without (control) or with or an antibody recognizing Sodium/Potassium ATPase alpha-3 ab2826 at a dilution of 1 : 20 over night at 4 °C washed with PBS and incubated with a DyLight-488 conjugated secondary antibody. Images were taken at 60X magnification.
- Flow Cyt
Unknown
Flow Cytometry - Anti-ATP1A3 antibody [XVIF9-G10] (AB2826)
Overlay histogram showing SH-SY5Y cells stained with ab2826 (red line). The cells were fixed with 4% paraformaldehyde and incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab2826, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
Please note that Abcam do not have any data for use of this antibody on non-fixed cells. We welcome any customer feedback.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ATP1A3 antibody [XVIF9-G10] (AB2826)
Immunohistochemistry was performed on both normal and cancer biopsies of deparaffinized Human tonsil tissue tissues. To expose target proteins heat induced antigen retrieval was performed using 10mM sodium citrate (pH6.0) buffer microwaved for 8-15 minutes. Following antigen retrieval tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Tissues were then probed at 1/200 dilution with ab2826 or without primary antibody (negative control) overnight at 4°C in a humidified chamber. Tissues were washed extensively with PBST and endogenous peroxidase activity was quenched with a peroxidase suppressor. Detection was performed using a biotin-conjugated secondary antibody and SA-HRP followed by colorimetric detection using DAB. Tissues were counterstained with hematoxylin and prepped for mounting.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ATP1A3 antibody [XVIF9-G10] (AB2826)
Immunofluorescent analysis of Sodium/Potassium ATPase alpha-3 using ab2826 shows staining in HeLa cells. Sodium/Potassium ATPase alpha-3 staining (green) F-Actin staining with Phalloidin (red) and nuclei with DAPI (blue) is shown. Cells were grown on chamber slides and fixed with formaldehyde prior to staining. Cells were probed without (control) or with or an antibody recognizing Sodium/Potassium ATPase alpha-3 ab2826 at a dilution of 1 : 20 over night at 4°C washed with PBS and incubated with a DyLight-488 conjugated secondary antibody. Images were taken at 60X magnification.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ATP1A3 antibody [XVIF9-G10] (AB2826)
Immunohistochemistry was performed on both normal and cancer biopsies of deparaffinized Human colon tissue tissues. To expose target proteins heat induced antigen retrieval was performed using 10mM sodium citrate (pH6.0) buffer microwaved for 8-15 minutes. Following antigen retrieval tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Tissues were then probed at 1/200 dilution with ab2826 or without primary antibody (negative control) overnight at 4°C in a humidified chamber. Tissues were washed extensively with PBST and endogenous peroxidase activity was quenched with a peroxidase suppressor. Detection was performed using a biotin-conjugated secondary antibody and SA-HRP followed by colorimetric detection using DAB. Tissues were counterstained with hematoxylin and prepped for mounting.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ATP1A3 antibody [XVIF9-G10] (AB2826)
Immunofluorescent analysis of Sodium/Potassium ATPase alpha-3 using ab2826 shows staining in C6 glioma cells. Sodium/Potassium ATPase alpha-3 staining (green) F-Actin staining with Phalloidin (red) and nuclei with DAPI (blue) is shown. Cells were grown on chamber slides and fixed with formaldehyde prior to staining. Cells were probed without (control) or with or an antibody recognizing Sodium/Potassium ATPase alpha-3 ab2826 at a dilution of 1 : 20 over night at 4 °C washed with PBS and incubated with a DyLight-488 conjugated secondary antibody. Images were taken at 60X magnification.
- WB
Supplier Data
Western blot - Anti-ATP1A3 antibody [XVIF9-G10] (AB2826)
Samples were electrophoresed using NuPAGE™ 4-12% Bis-Tris Protein Gel. Resolved proteins were then transferred onto a Nitrocellulose membrane by iBlot® 2 Dry Blotting System. Chemiluminescent detection was performed using Novex® ECL Chemiluminescent Substrate Reagent Kit.
All lanes:
Western blot - Anti-ATP1A3 antibody [XVIF9-G10] (ab2826) at 1 µg/mL
Lane 1:
SH-SY5Y (Human neuroblastoma cell line from bone marrow) whole cell lysate at 30 µg
Lane 2:
IMR-32 (Human brain neuroblast cell line) whole cell lysate at 30 µg
Lane 3:
SK-OV-3 (Human ovarian cancer cell line) whole cell lysate at 30 µg
Lane 4:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 30 µg
Lane 5:
Mouse brain tissue lysate at 30 µg
Secondary
All lanes:
Goat anti-Mouse IgG (H+L) Superclonal™ Recombinant Secondary Antibody, HRP at 1/4000 dilution
Predicted band size: 111 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The sodium-potassium ATPase where ATP1A3 serves acts as a vital component in maintaining ion homeostasis. This protein resides in cell membranes and forms a part of the larger complex required for normal neuron function. Its activity also influences other cell functions like cell volume regulation and signal transduction processes. The alpha3 subunit specifically exhibits specialized roles in neuronal tissues where rapid Na+ and K+ exchange is necessary contributing significantly to nerve impulse transmission.
Pathways
The function of ATP1A3 is integral in the maintenance of the membrane potential which is an important part of many physiological pathways including the action potential propagation in neurons. Another pathway where its activity is significant involves synaptic vesicle cycling which depends on ATP1A3 to maintain ionic conditions for synaptic transmission. Proteins such as the beta subunit of the sodium-potassium ATPase ATP1B1 closely associate with ATP1A3 and modulate its activity and stability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 15:363 PubMed38796484
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature neuroscience 27:433-448 PubMed38267524
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35563009
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of comparative neurology 530:627-647 PubMed34415061
2021
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical pharmacology 182:114226 PubMed32976831
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 11:861 PubMed32581812
2020
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 5: PubMed31941841
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 294:19119-19136 PubMed31694913
2019
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 20: PubMed31661838
2019
Applications
Unspecified application
Species
Unspecified reactive species
eLife 8: PubMed30672734
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com